結構式 |
|
2-(Cyclohexylcarbonyl) -1,2,3,6,7,11b-hexahydro-4H-pyrazino (2,1-alpha) isoquinolin-4-one
|
UpToDate |
UpToDate 連結
|
藥理作用 |
|
本品為吸蟲驅除劑。它與吸蟲外皮膜磷脂質相互作用使蟲之膜構造成不安定化,促進Ca++往吸蟲之流入,已流入吸蟲體內之Ca++,使吸蟲之肌肉收縮,並造成吸蟲外皮構造之損傷(空胞化等)。
|
適應症 |
|
由血吸蟲屬感染引起的病症:埃及血吸蟲、日本血吸蟲、中華肝吸蟲、肺吸蟲。
|
用法用量 |
|
1次20mg/kg,1天2次,服用2天。日本吸蟲症:1天1∼2次,服用1天。
|
藥動力學 |
|
Absorption Rapidly absorbed (80%). T max is 1 to 3 h. Distribution CSF levels are 14% to 20% of plasma concentration. Appears in breast milk. Protein binding is 80% to 85%. Metabolism Extensive first-pass metabolism, rapidly metabolized to inactive mono- and polyhydroxylated derivatives. Elimination Urine (as metabolites), small amounts in feces. Serum t ½ is 0.8 to 1.5 h.
Special Populations Hepatic Function Impairment Moderate to severe; plasma concentration were significantly elevated in one study.
|
副作用 |
|
1. 肝:肝檢查值異常。 2. 血液:紅血球、血小板減少,嗜酸性血球增多,白血球增加。 3. 噁心、嘔吐,間有腹痛。 4. 頭痛、頭重感、間有思眠、眩暈。
|
交互作用 |
|
Cimetidine Plasma levels of praziquantel may be elevated, increasing the pharmacologic and adverse effects.
|
禁忌 |
|
對本藥成份過敏者
|
注意事項 |
|
1.有釣條蟲症患者,禁用本品。 2.治療2個月後檢定病患的寄生蟲是否完全根除。
|
藥品保存方式 |
|
藥品應置於攝氏 15 ~ 25 度乾燥處所;如發生變質或過期,不可再食用。
|